Bicocca Open Archive

Logo unimib boa

Mahil, S., Schaefer, M., Dand, N., Yiu, Z., Hyrich, K., Strangfeld, A., et al. (2022). Risk of severe COVID-19 associated with immune-modifying drugs: Data from PsoProtect and Global Rheumatology Alliance registries.. In 51st Annual Meeting of the European-Society-for-Dermatological-Research (ESDR) (pp.193-193). Elsevier Ltd [10.1016/j.jid.2022.09.086].

Risk of severe COVID-19 associated with immune-modifying drugs: Data from PsoProtect and Global Rheumatology Alliance registries.

Carugno A
Membro del Collaboration Group
;
2022
abstract + poster
Psoriasis, COVID-19; immune-modifying drugs
English
51st Annual Meeting of the European-Society-for-Dermatological-Research (ESDR) 28 Settembre-1 Ottobre 2022
2022
51st Annual Meeting of the European-Society-for-Dermatological-Research (ESDR)
2022
142
S12
193
193
076
none
Mahil, S., Schaefer, M., Dand, N., Yiu, Z., Hyrich, K., Strangfeld, A., et al. (2022). Risk of severe COVID-19 associated with immune-modifying drugs: Data from PsoProtect and Global Rheumatology Alliance registries.. In 51st Annual Meeting of the European-Society-for-Dermatological-Research (ESDR) (pp.193-193). Elsevier Ltd [10.1016/j.jid.2022.09.086].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/452424
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact